U-Blot® Fremanezumab Polyclonal AntibodyCat. No. WP26425Request quote
Size: 50μL/100μL
Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.
U-Blot® Fremanezumab Polyclonal AntibodyCat. No. WP26425
U-Blot® Cemiplimab Polyclonal AntibodyCat. No. WP26424
U-Blot® Emapalumab Polyclonal AntibodyCat. No. WP26423
U-Blot® Ravulizumab Polyclonal AntibodyCat. No. WP26422
U-Blot® Caplacizumab Polyclonal AntibodyCat. No. WP26421
U-Blot® Romosozumab Polyclonal AntibodyCat. No. WP26420
U-Blot® Risankizumab Polyclonal AntibodyCat. No. WP26419
U-Blot® Polatuzumab Polyclonal AntibodyCat. No. WP26418
U-Blot® Crizanlizumab Polyclonal AntibodyCat. No. WP26417
U-Blot® Enfortumab Polyclonal AntibodyCat. No. WP26416
U-Blot® Eptinezumab Polyclonal AntibodyCat. No. WP26415
U-Blot® Isatuximab Polyclonal AntibodyCat. No. WP26414